Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$11.42 - $17.05 $1,142 - $1,705
100 New
100 $1,000
Q3 2021

Nov 05, 2021

SELL
$11.39 - $16.23 $7,984 - $11,377
-701 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$13.22 - $19.09 $9,267 - $13,382
701 New
701 $10,000
Q1 2021

May 24, 2021

SELL
$16.68 - $23.97 $11,692 - $16,802
-701 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$15.21 - $25.53 $10,662 - $17,896
701 New
701 $11,000

Others Institutions Holding KNSA

About Kiniksa Pharmaceuticals, Ltd.


  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $680M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.